JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC

EIN: 954043560 501(c)(3)

LOS ANGELES, CA

Total Revenue
$376,798
Total Expenses
$517,570
Total Assets
$312,014
Net Assets
$271,648
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1985
Legal Domicile
CA
Principal Officer
JAY N SCHAPIRA
Phone
3106592030
Tax Period
2023-12-01 to 2024-11-30

JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC, founded in 1985, is a small nonprofit that reported $377K in total revenue in fiscal year 2023. Revenue grew 17% year-over-year, indicating healthy expansion. Expenses of $518K exceeded revenue, resulting in a 37% operating deficit.

Mission

RESEARCH IN CARDIAC DISEASE IN ORDER TO UNDERSTAND THE CAUSE AND DEVELOP TREATMENT STRATEGIES FOR PATIENTS WITH SYSTEMIC LUPIS ERYTHEMATOSUS TO DEVELOP NOVEL NON-PHARMACOLOGIC TREATMENT APPROACHES TO RELIEVE ANGINA PECTORIS.RESEARCH INTO CORONARY ARTERY IMAGING IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI). SPECIFICALLY EVALUATING THE UTILITY OF OCT (OPTIONAL COHERENCE TOMOGRAPHY) TO ASSIST IN OPTIMIZING THE RESULTS OF PCI.

Program Service Accomplishments

Program 1
Expenses: $458,079 Revenue: $345,918

PHASE I - INVESTIGATING THE CELLULAR ORIGIN OF RESIDENT CARDIAC STEM CELLS (CARDIOSPHERES) AND CLINICALLY ISOLATING THEM AND PREPARING TO DETERMINE THEIR BIOLOGY SO THAT THEY MIGHT BE INFUSED INTO...

Read more

PHASE I - INVESTIGATING THE CELLULAR ORIGIN OF RESIDENT CARDIAC STEM CELLS (CARDIOSPHERES) AND CLINICALLY ISOLATING THEM AND PREPARING TO DETERMINE THEIR BIOLOGY SO THAT THEY MIGHT BE INFUSED INTO HEART ATTACK VICTIMS.PHASE II - INVESTIGATING INTO THE SIGNIFICANCE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN PATIENTS UNDERGOING PRIMARY CORONARY INTERVENTIONS WITH DRUG-ELUTING STENTS AND COLLECTING DATA ON ENDOTHELIAL PROGENITOR CELLS AT THE TIME OF THESE PROCEDURES.PHASE III - CONTINUING THE RANDOMIZED EVALUATION OF INTRACORONARY TRANSPLANTATION OF BONE MARROW STEM CELLS IN ACUTE MYOCARDIAL INFARCTION CHARACTERIZED BY ST SEGMENT ELEVATION AND TRANSMURAL INFARCTS. INVESTIGATION OF MICROVASCULAR ISCHEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ASCERTAIN IMPROVED, ACCURATE DIAGNOSTIC PROCEDURES.TREATMENT OF CORONARY ARTERY DISEASE, ESPECIALLY REVASCULARIZATION OF THE LEFT MAIN CORONARY ARTERY (PERCUTANEOUS CORONARY INTERVENTION IN UNPROTECTED LEFT MAIN DISEASE).EVAULATION AND TREATMENT OF CHEST PAIN CAUSED BY MICROVASCULAR ISCHEMIA FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PUBLISH RESULTS.EDUCATIONAL PUBLICATION FOR MULTIFACET TREATMENT OF ATRIAL FIBRILLATION BY MEDICATION AND DEVICE.CLASSIFICATION AND CHARACTERIZATION OF COMPLEX CORONARY ARTERY STENOSIS MORPHOLOGY BY CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY.DUE TO THE RECOGNITION OF DR. JAY N SCHAPIRA'S (THE PRESIDENT OF THE FOUNDATION) ACCOMPLISHMENTS AND RESEARCH, HE WAS APPOINTED A CLINICAL PROFESSOR OF MEDICINE AT THE CEDARS-SINAI HEART INSTITUTE IN MAY 2014.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $30,880
Program Service Revenue $0
Investment Income $345,918
Other Revenue $0
TOTAL REVENUE $376,798

Expense Breakdown

Grants Paid $0
Salaries & Benefits $456,890
Fundraising Expenses $0
Program Expenses $458,079
Other Expenses $60,680
TOTAL EXPENSES $517,570

Year-over-Year Comparison

2023 2022 Change
Revenue $376,798 $321,538 +0.2%
Expenses $517,570 $514,090 +0.0%
Net Income $-140,772 $-192,552 -0.3%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
6
Independent Members
3
Employees
7
Volunteers
N/A

Governance Policies

✓ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$822,000
Total Directors
5
$822,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JAY N SCHAPRIA MD PRESIDENT/DIRECTOR 15.00
Officer Director
$222,000 $0 $822,000
PHYLLIS SCHAPIRA SECRETARY/DIRECTOR 0.30
Officer Director
$0 $0 $0
ROBERT KASS MD DIRECTOR 0.30
Director
$0 $0 $0
RONALD FISK MD DIRECTOR 0.30
Director
$0 $0 $0
BERNARD BUBMAN DIRECTOR 0.30
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $376,798 $517,570 $312,014 $-140,772
2023 $321,538 $514,090 $466,771 $-192,552
2022 $70,397 $495,102 $654,323 $-424,705
2021 $389,431 $434,990 $1,113,462 $-45,559
2020 $119,123 $404,633 $718,786 $-285,510
2019 $114,721 $414,430 $913,963 $-299,709
2018 $187,555 $422,071 $1,214,885 $-234,516
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare JAY N SCHAPIRA MD MEDICAL RESEARCH FOUNDATION INC with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.